ORCID as entered in ROS

Select Publications
2019, 'Prognostic value of the volume time index (VTI) ratio for patients with appendiceal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e15704
,2015, 'Monepantel a new first in class potent inhibitor of P70S6K potentiates the anti-tumor effects of gemcitabine and doxorubicin: In vitro and in vivo studies', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-005
,2015, 'Synergistic inhibition of human gastric and colorectal cancers by Bromelain and N-acetylcysteine: An in vivo study', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 75, presented at 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 18 April 2015 - 22 April 2015, http://dx.doi.org/10.1158/1538-7445.AM2015-LB-007
,2015, 'BROMELAIN AND N-ACETYLCYSTEINE INHIBIT PROLIFERATION AND SURVIVAL OF GASTROINTESTINAL CANCER CELLS: SIGNIFICANCE OF COMBINATION THERAPY', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 27 - 27, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv094.6
,2015, 'IN VIVO ASSESSMENT OF GROWTH-INHIBITORY AND MUCIN-DEPLETING EFFECTS OF BROMELAIN AND N-ACETYLCYSTEINE IN PERITONEAL CARCINOMATOSIS MODELS', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 28 - 28, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv095.3
,2015, 'SPROUTY 2 PROTEIN, BUT NOT SPROUTY 4, IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR HUMAN EPITHELIAL OVARIAN CANCER', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, FRANCE, Paris, Vol. 26, pp. 22 - 22, presented at 13th International Congress on Targeted Anticancer Therapies (TAT), FRANCE, Paris, 02 March 2015 - 04 March 2015, http://dx.doi.org/10.1093/annonc/mdv092.4
,